None
[更多]
This is a new methodof improving the treatment of NSCLC and other cancers. It involvesadministering a novel combination of ascorbate and a metal chelating agent,such as ethylene diamine tetraacetic acid (EDTA), to increase tumor cellssensitivity to common cancer treatment options. When this combinat.....
[更多]
| |< <- | [6508] [6509] [6510] [6511] [6512] [6513] [6514] [6515] [6516] [6517] [6518] | -> >| |
